Literature DB >> 212923

Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis.

K Nagashima, H Wege, R Meyermann, V ter Meulen.   

Abstract

Thirty percent of weanling rats infected with JHM murine corona virus developed a subacute demyelinating encephalomyelitis approximately 3 weeks after intracerebral inoculation. Small demyelinating foci were located in the deep cerebral white matter and large, sharply demarcated demyelinating lesions were detectabll preserved in the demyelinating plaques in areas where the lesions extended to the gray matter. Perivascular cuffings, consisting of plasma cells and mononuclear cells, were frequently found. Viral antigen was found mostly in the white matter and in glial cells, leaving neurons unstained. Electron microscopic studies of the early lesions of white matter disclosed two different kinds of cell degeneration which developed prior to the myelin disruption and mononuclear cell infiltration. One was a small pyknotic cell, which is thought to be an oligodendrocyte and the other is a ballooned cell containing abundant microtubules. Virus particles could be demonstrated only in the latter cell type. Discussion about astrocytes as well as oligodendrocytes was made in relation to the initial stage of demyelination caused by virus infection. This animal model may be useful in the analysis of the mechanisms leading to demyelination in subacute or chronic infections.

Entities:  

Mesh:

Year:  1978        PMID: 212923      PMCID: PMC7086507          DOI: 10.1007/bf00691641

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Electron microscopic autoradiographic studies of gliogenesis in rat optic nerve. I. Cell proliferation.

Authors:  R P Skoff; D L Price; A Stocks
Journal:  J Comp Neurol       Date:  1976-10-01       Impact factor: 3.215

2.  Early and late CNS-effects of corona virus infection in rats.

Authors:  K Nagashima; H Wege; V ter Meulen
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

3.  Pathogenesis of demyelination induced by a mouse hepatitis.

Authors:  L P Weiner
Journal:  Arch Neurol       Date:  1973-05

4.  Observations on viral demyelinating encephalomyelitis. Canine distemper.

Authors:  H Wiśniewski; C S Raine; W J Kay
Journal:  Lab Invest       Date:  1972-05       Impact factor: 5.662

5.  An electron microscopic analysis of gliogenesis in rat optic nerves.

Authors:  J E Vaughn
Journal:  Z Zellforsch Mikrosk Anat       Date:  1969

6.  Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis.

Authors:  P Lampert
Journal:  Acta Neuropathol       Date:  1967-10-20       Impact factor: 17.088

7.  Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies.

Authors:  P W Lampert; J K Sims; A J Kniazeff
Journal:  Acta Neuropathol       Date:  1973-03-30       Impact factor: 17.088

8.  On the development of CNS lesions in natural canine distemper encephalomyelitis.

Authors:  C S Raine
Journal:  J Neurol Sci       Date:  1976-11       Impact factor: 3.181

9.  Infectious leukoencephalitis. A critical comparison of certain experimental and naturally-occurring viral leukoencephalitides with experimental allergic encephalomyelitis.

Authors:  B H WAKSMAN; R D ADAMS
Journal:  J Neuropathol Exp Neurol       Date:  1962-10       Impact factor: 3.685

10.  A MURINE VIRUS (JHM) CAUSING DISSEMINATED ENCEPHALOMYELITIS WITH EXTENSIVE DESTRUCTION OF MYELIN : II. PATHOLOGY.

Authors:  O T Bailey; A M Pappenheimer; F S Cheever; J B Daniels
Journal:  J Exp Med       Date:  1949-08-31       Impact factor: 14.307

View more
  61 in total

1.  Analysis of age-dependent resistance to murine coronavirus JHM infection in mice.

Authors:  K Pickel; M A Müller; V ter Meulen
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

2.  Macrophage antiviral activity: extrinsic versus intrinsic activity.

Authors:  S A Stohlman; J G Woodward; J A Frelinger
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

3.  Coronavirus isolates SK and SD from multiple sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus OC43, but not to human coronavirus 229E.

Authors:  J C Gerdes; I Klein; B L DeVald; J S Burks
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

4.  Coronavirus JHM-induced demyelinating encephalomyelitis in rats: influence of immunity on the course of disease.

Authors:  H Wege; R Watanabe; M Koga; V Ter Meulen
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

5.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Demyelination in mice resulting from infection with a mutant of Semliki Forest virus.

Authors:  B J Sheahan; P N Barrett; G J Atkins
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.

Authors:  J M Pasick; S Dales
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

Authors:  O Sorensen; M B Coulter-Mackie; S Puchalski; S Dales
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

9.  Coronavirus JHM: cell-free synthesis of structural protein p60.

Authors:  S G Siddell; H Wege; A Barthel; V ter Meulen
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

10.  Semliki forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells.

Authors:  G J Atkins; B J Sheahan
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.